Similar articles for PMID: 33451990

Year	Number of Results
2002	1
2003	1
2008	3
2009	2
2010	1
2012	2
2013	1
2014	4
2015	2
2016	5
2017	10
2018	23
2019	25
2020	24
2021	6

1

Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States.

Chang SH, Merzkani M, Lentine KL, Wang M, Axelrod DA, Anwar S, Schnitzler MA, Wellen J, Chapman WC, Alhamad T. Chang SH, et al. Clin J Am Soc Nephrol. 2021 Feb 8;16(2):251-261. doi: 10.2215/CJN.10960720. Epub 2021 Jan 15. Clin J Am Soc Nephrol. 2021. PMID: 33451990

2

Trends in utilization of deceased donor kidneys based on hepatitis C virus status and impact of public health service labeling on discard.

Ariyamuthu VK, Sandikci B, AbdulRahim N, Hwang C, MacConmara MP, Parasuraman R, Atis A, Tanriover B. Ariyamuthu VK, et al. Transpl Infect Dis. 2020 Feb;22(1):e13204. doi: 10.1111/tid.13204. Epub 2019 Nov 26. Transpl Infect Dis. 2020. PMID: 31677214

3

National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys.

Potluri VS, Goldberg DS, Mohan S, Bloom RD, Sawinski D, Abt PL, Blumberg EA, Parikh CR, Sharpe J, Reddy KR, Molnar MZ, Sise M, Reese PP. Potluri VS, et al. J Am Soc Nephrol. 2019 Oct;30(10):1939-1951. doi: 10.1681/ASN.2019050462. Epub 2019 Sep 12. J Am Soc Nephrol. 2019. PMID: 31515244 Free PMC article.

4

Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients.

Eckman MH, Woodle ES, Thakar CV, Alloway RR, Sherman KE. Eckman MH, et al. Am J Kidney Dis. 2020 Jun;75(6):857-867. doi: 10.1053/j.ajkd.2019.11.005. Epub 2020 Feb 17. Am J Kidney Dis. 2020. PMID: 32081494

5

Are we underestimating the quality of aviremic hepatitis C-positive kidneys? Time to reconsider.

Sibulesky L, Kling CE, Blosser C, Johnson CK, Limaye AP, Bakthavatsalam R, Leca N, Perkins JD. Sibulesky L, et al. Am J Transplant. 2018 Oct;18(10):2465-2472. doi: 10.1111/ajt.14701. Epub 2018 Mar 14. Am J Transplant. 2018. PMID: 29451354 Free article.

6

Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals.

La Hoz RM, Sandıkçı B, Ariyamuthu VK, Tanriover B. La Hoz RM, et al. Am J Transplant. 2019 Nov;19(11):3058-3070. doi: 10.1111/ajt.15496. Epub 2019 Aug 7. Am J Transplant. 2019. PMID: 31207073 Free PMC article.

7

Factors leading to the discard of deceased donor kidneys in the United States.

Mohan S, Chiles MC, Patzer RE, Pastan SO, Husain SA, Carpenter DJ, Dube GK, Crew RJ, Ratner LE, Cohen DJ. Mohan S, et al. Kidney Int. 2018 Jul;94(1):187-198. doi: 10.1016/j.kint.2018.02.016. Epub 2018 May 5. Kidney Int. 2018. PMID: 29735310 Free PMC article.

8

Epidemiology of Kidney Discard from Expanded Criteria Donors Undergoing Donation after Circulatory Death.

Singh SK, Kim SJ. Singh SK, et al. Clin J Am Soc Nephrol. 2016 Feb 5;11(2):317-23. doi: 10.2215/CJN.07190715. Epub 2015 Dec 14. Clin J Am Soc Nephrol. 2016. PMID: 26668028 Free PMC article.

9

Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy.

Bowring MG, Kucirka LM, Massie AB, Ishaque T, Bae S, Shaffer AA, Garonzik Wang J, Sulkowski M, Desai N, Segev DL, Durand CM. Bowring MG, et al. Transplantation. 2018 Dec;102(12):2088-2095. doi: 10.1097/TP.0000000000002323. Transplantation. 2018. PMID: 29912046 Free PMC article.

10

Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?

Cannon RM, Locke JE, Orandi BJ, Anderson DJ, Davis EG, Mackelaite L, Dave H, Eng M, Jones CM. Cannon RM, et al. Transplantation. 2020 Jun;104(6):1215-1228. doi: 10.1097/TP.0000000000002949. Transplantation. 2020. PMID: 31517783 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed